ASM Microbe: GeoVax present single-dose vaccines for Ebola, Lassa and Zika

At ASM Microbe (7–11 June, Atlanta, GA, USA) researchers from GeoVax (GA, USA) have presented their flexible ‘Plug and Play’ platform technology that could deliver a single-dose vaccine to fully protect against key emerging diseases.

“Unlike other vaccine technologies currently available, which sacrifice confidence in success for speed or vice-versa, the GeoVax technology offers a true ‘Plug and Play’ platform approach that is well suited for use against a wide range of biological threats and amenable to rapid, large-scale production,” commented Rahul Basu, a scientist at GeoVax.

Restricted Content / Members Only

You cannot view this content because It is available to members only. Please or Register to view this area.


Leave A Comment